ImageneBio IMA
NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT

ImageneBio (IMA) Retained Earnings (2020 - 2025)

ImageneBio's (IMA) quarterly Retained Earnings came in at $363.1 million in Q4 2025, up 301.83% year-over-year from $90.4 million in Q4 2024, and little changed quarter-over-quarter from $362.9 million in Q3 2025.

Analysis

ImageneBio (IMA) Retained Earnings (2020 - 2025) Analysis & Trends

ImageneBio has disclosed Retained Earnings across 6 years of filings, most recently posting $363.1 million for Q4 2025.

  • In Q4 2025, Retained Earnings rose 301.83% year-over-year to $363.1 million; the TTM figure through Dec 2025 stood at $363.1 million (up 301.83% YoY), while the FY2025 annual figure was $363.1 million, up 301.83% from the prior year.
  • Retained Earnings came in at $363.1 million for Q4 2025 at ImageneBio, roughly flat from $362.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $458.8 million in Q2 2025 to a low of -$179.9 million in Q4 2024.
  • Average Retained Earnings over 5 years is $365.3 million, with a median of $363.0 million recorded in 2025.
  • Year-over-year, Retained Earnings surged 417.31% in 2021 and sank 139.79% in 2024.
  • Over 5 years, Retained Earnings stood at $353.3 million in 2021, then increased by 2.44% to $361.9 million in 2022, then climbed by 24.93% to $452.1 million in 2023, then slumped by 139.79% to -$179.9 million in 2024, then surged by 301.83% to $363.1 million in 2025.
  • Per Business Quant data, the three most recent Retained Earnings figures were $363.1 million in Q4 2025, $362.9 million in Q3 2025, and $458.8 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 ImageneBio 42.89 Mn -92.46 Mn - 363.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 363.09 Mn
Sep 30, 2025 362.87 Mn
Jun 30, 2025 458.80 Mn
Mar 31, 2025 458.34 Mn
Dec 31, 2024 -179.90 Mn
Sep 30, 2024 456.44 Mn
Jun 30, 2024 455.42 Mn
Mar 31, 2024 454.14 Mn
Dec 31, 2023 452.14 Mn
Sep 30, 2023 418.49 Mn
Jun 30, 2023 402.67 Mn
Mar 31, 2023 363.92 Mn
Dec 31, 2022 361.92 Mn
Sep 30, 2022 360.06 Mn
Jun 30, 2022 358.22 Mn
Mar 31, 2022 355.69 Mn
Dec 31, 2021 353.30 Mn
Sep 30, 2021 351.48 Mn
Jun 30, 2021 349.96 Mn
Mar 31, 2021 348.66 Mn